Skip to main content
Premium Trial:

Request an Annual Quote

ExonHit Extends License for Ariadne's Pathway Software

NEW YORK (GenomeWeb News) - ExonHit Therapeutics has extended its license for Ariadne’s Pathway Studio software for its research projects in alternative RNA splicing, Ariadne said today.
 
Under the agreement, ExonHit will continue to use Pathway Studio in collaborations with drug development partners.
 
The software extracts functional relationships of genes, proteins, small molecules, cell processes, and diseases from the scientific literature and presents it in a database that can be used for analysis and for validating hypotheses.
 
ExonHit’s vice president of business development, John Jaskowiak, said the company has integrated the software into its target discovery processes “in order to identify pathways of interest and to prioritize splicing events that we will explore further in our research programs.”
 
Financial terms of the agreement were not released.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.